Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tolulope Adeyelu

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
NPJ Precision Oncology|September 4, 2024
Efficacy of PARP inhibitor therapy after targeted BRAF/MEK failure in advanced melanomaJordan Phillipps, George Nassief, Renee Morecroft, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 14, 2025
First Cases of NUT Carcinoma Harboring NUTM2 Gene RearrangementsMark G Evans, Sara O Vargas, Adam Bedeir, et al.
Scientific Reports|September 2, 2017
Structural and Functional View of PolypharmacologyAurelio Moya-García, Tolulope Adeyelu, Felix A Kruger, et al.
Journal of the American College of Surgeons|April 23, 2024
Genomic and Transcriptomic Landscape of RET Wild-Type Medullary Thyroid Cancer and Potential Use of Mitogen-Activated Protein Kinase-Targeted TherapySourat Darabi, Tolulope Adeyelu, Andrew Elliott, et al.
Scientific Reports|February 10, 2024
ARID2 mutations may relay a distinct subset of cutaneous melanoma patients with different outcomesFavour A Akinjiyan, George Nassief, Jordan Phillipps, et al.
Acta Neuropathologica Communications|February 24, 2026
Unveiling ribosomal dysfunction and impaired signaling pathways in the cortical region of 5xFAD miceKirti Agrawal, Blessing C Egbejiogu, Tolulope Adeyelu, et al.
JCO Precision Oncology|January 14, 2026
Homologous Recombination Deficiency in Skin Cancers: Prevalence and Clinical Implications of This Distinct Patient CohortGeorge Nassief, Tolulope Adeyelu, Andrew Elliott, et al.
Head & Neck|November 12, 2025
Genomic and Immune Correlates of EZH2 Expression and Activity in Olfactory NeuroblastomaElisabetta Xue, Tolulope Adeyelu, Harris Krause, et al.
JCO Precision Oncology|December 5, 2024
Genomic Landscape of Malignant Phyllodes Tumors Identifies Subsets for Targeted TherapyRani Bansal, Tolulope Adeyelu, Andrew Elliott, et al.
JCO Precision Oncology|June 8, 2026
Integrated Molecular and Clinical Analysis of Thymic Epithelial TumorsChul Kim, Tolulope Adeyelu, Rohan Maniar, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
NPJ Precision Oncology|September 4, 2024
Efficacy of PARP inhibitor therapy after targeted BRAF/MEK failure in advanced melanomaJordan Phillipps, George Nassief, Renee Morecroft, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 14, 2025
First Cases of NUT Carcinoma Harboring NUTM2 Gene RearrangementsMark G Evans, Sara O Vargas, Adam Bedeir, et al.
Scientific Reports|September 2, 2017
Structural and Functional View of PolypharmacologyAurelio Moya-García, Tolulope Adeyelu, Felix A Kruger, et al.
Journal of the American College of Surgeons|April 23, 2024
Genomic and Transcriptomic Landscape of RET Wild-Type Medullary Thyroid Cancer and Potential Use of Mitogen-Activated Protein Kinase-Targeted TherapySourat Darabi, Tolulope Adeyelu, Andrew Elliott, et al.
Scientific Reports|February 10, 2024
ARID2 mutations may relay a distinct subset of cutaneous melanoma patients with different outcomesFavour A Akinjiyan, George Nassief, Jordan Phillipps, et al.
Acta Neuropathologica Communications|February 24, 2026
Unveiling ribosomal dysfunction and impaired signaling pathways in the cortical region of 5xFAD miceKirti Agrawal, Blessing C Egbejiogu, Tolulope Adeyelu, et al.
JCO Precision Oncology|January 14, 2026
Homologous Recombination Deficiency in Skin Cancers: Prevalence and Clinical Implications of This Distinct Patient CohortGeorge Nassief, Tolulope Adeyelu, Andrew Elliott, et al.
Head & Neck|November 12, 2025
Genomic and Immune Correlates of EZH2 Expression and Activity in Olfactory NeuroblastomaElisabetta Xue, Tolulope Adeyelu, Harris Krause, et al.
JCO Precision Oncology|December 5, 2024
Genomic Landscape of Malignant Phyllodes Tumors Identifies Subsets for Targeted TherapyRani Bansal, Tolulope Adeyelu, Andrew Elliott, et al.
JCO Precision Oncology|June 8, 2026
Integrated Molecular and Clinical Analysis of Thymic Epithelial TumorsChul Kim, Tolulope Adeyelu, Rohan Maniar, et al.
Pageof 3